Dendritic Cells Archive - Seite 7 von 106 - IOZK

Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial)

2022-06-16/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-06-16 / BMJ Open 2022 Jun;12(6):e060431

Combination Neoantigen-Based Dendritic Cell Vaccination and Adoptive T-Cell Transfer Induces Antitumor Responses Against Recurrence of Hepatocellular Carcinoma

2022-06-03/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-06-03 / Cancer Immunol Res 2022 Jun;10(6):728-744

Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer: A phase I study

2022-04-28/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2022-04-28 / Eur J Cancer 2022 Jul;169:20-31

Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades

2022-04-28/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2022-04-28 / J Cancer Res Clin Oncol 2023 Apr;149(4):1425-1441

Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory acute leukemia

2022-03-10/in Acute Leukemia, Dendritic Cells, International Publications /von 2022-03-10 / Ther Apher Dial 2022 Jun;26(3):537-547

A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis

2022-03-08/in Dendritic Cells, Glioblastoma, International Publications /von 2022-03-08 / Expert Rev Vaccines 2022 Apr;21(4):513-531

Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients

2022-02-16/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2022-02-16 / Genes Immun 2022 Feb;

Wilms‘ tumor 1 peptide-loaded dendritic cell vaccination in patients with relapsed or refractory malignant lymphoma

2022-02-15/in Dendritic Cells, International Publications, Malignant Lymphoma /von 2022-02-15 / Leuk Lymphoma 2022 Jul;63(7):1733-1737

Delayed Effect of Dendritic Cells Vaccination on Survival in Glioblastoma: A Systematic Review and Meta-Analysis

2022-02-04/in Dendritic Cells, Glioblastoma, International Publications /von 2022-02-04 / Curr Oncol 2022 Feb;29(2):881-891

Research progress on dendritic cell vaccines in cancer immunotherapy

2022-01-24/in Dendritic Cells, International Publications /von 2022-01-24 / Exp Hematol Oncol 2022 Jan;11(1):3